NACDS posted an NACDS RxIMPACT action alert, urging Oklahomans to contact their State Representative and State Senator to override Gov. Kevin Stitt's (R) veto of critical PBM reform legislation, SB 2074, which sets a minimum reimbursement rate based on NADAC and requires a dispensing fee equal to or greater than the Medicaid fee-for-service rate. 

Also in Oklahoma, NACDS sent Gov. Kevin Stitt (R) a letter urging him to sign SB 401, a Food is Medicine bill that grants the Oklahoma Health Care Authority the authority to accept, receive and expend federal funds, grants, cooperative agreements or demonstration model funding awarded by CMS. This model will provide nutrition support services to eligible women who have a diet-related condition or a disease that may contribute to a high-risk pregnancy or birth complications. Nutrition services will include medically tailored home-delivered meals and may also include nutritional counseling, although recipients are not required to undergo counseling to receive the meals. 

Also in Oklahoma, NACDS sent a letter to Gov. Stitt, urging him to sign three additional PBM reform bills: SB 1500, SB 1447 and SB 2007. Collectively, these measures aim to address persistent issues related to PBM marketplace manipulation and ensure Oklahomans continue to have reliable, convenient access to their trusted community pharmacies. 

Finally in Oklahoma, NACDS sent a letter to Gov. Stitt, urging him to sign SB 1565, legislation that will strengthen maternal healthcare and nutrition services for Medicaid beneficiaries through participation in the federal Transforming Maternal Health Model. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

NACDS collaborated with the Oklahoma Pharmacy Association to advance four critical PBM reform bills. SB 2074, which establishes a pharmacy reimbursement rate floor—setting NADAC plus a dispensing fee that cannot fall below the Medicaid fee-for-service rate for both commercial and state plans—was heard by the House Public Health Committee on April 8. The committee also considered two additional PBM reform bills, including SB 1500 and SB 2007. On April 7, the House Insurance Committee heard SB 1447. NACDS submitted letters voicing strong support for all four bills, which would implement essential PBM reforms.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

On March 26, the Senate passed SB 2074 by a decisive 34-3 vote. This bill aims to establish a reimbursement rate floor of NADAC plus a dispensing fee that cannot be lower than the Medicaid fee-for-service rate. The legislation was reported to the House for further consideration.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

The Legislature will convene on February 2 and is scheduled to adjourn on May 29.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

The legislature convened an interim hearing to examine the influence of PBMs on prescription drug pricing and patient access to local pharmacies. Chaired by Sen. Spencer Kern (R) and pharmacist Rep. T.J. Marti (R), the session highlighted significant concerns regarding below-cost pharmacy reimbursements, opaque pricing structures and patient steering practices. Expert testimony by Antonio Ciaccia, 46brooklyn Research, and others underscored systemic incentives that diminish transparency and raise costs. The Attorney General’s office and the Insurance Department reported recovering $32 million through enforcement actions, positioning Oklahoma as a national leader in PBM oversight. Legislators signaled intent to pursue comprehensive PBM reform legislation again in 2026, aimed at enhancing transparency, safeguarding independent pharmacies and ensuring equitable drug pricing.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

On September 9, the Attorney General Gentner Drummond (R) announced a $32.1 million settlement with CVS Caremark, a PBM for the state's HealthChoice plan. The settlement resolves allegations that CVS Caremark withheld millions of dollars in drug rebates intended to reduce healthcare costs for state employees between January 2020 and December 2024. Approximately $27 million, after attorney fees, will be returned to HealthChoice within 30 days to benefit state employees, retirees and their families. The agreement also mandates quarterly rebate reporting, prompt rebate remittance and expanded definitions to ensure transparency and accountability.  

Also in Oklahoma, NACDS submitted the state survey on the Rural Health Transformation Program funds. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

The Board of Pharmacy posted the quarterly newsletter.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

The US Supreme Court has declined to review the PCMA v. Mulready case, marking a significant setback for efforts to protect patients and pharmacies from harmful practices by PBMs. This decision upholds the 10th Circuit’s ruling, which struck down key provisions of the state’s Patient’s Right to Pharmacy Choice Act on the grounds that they are preempted by ERISA and Medicare Part D. As a result, the state now faces limited options for safeguarding pharmacies and ensuring patient access to the medications they need.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Gov. Kevin Stitt (R) appointed, and the Legislature confirmed Walmart pharmacist Shannon Griggs to serve a five-year term on the Board of Pharmacy, beginning July 1 and expiring June 30, 2030. Griggs is replacing Mark St. Cyr. 

Also in Oklahoma, SB 789, a PBM reform bill banning effective rate contracts, providing network transparency and reimbursement appeal protections, was enacted without Gov. Kevin Stitt's (R) signature. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.